Consonance Capital

Consonance Capital Management as of March 31, 2021

Portfolio Holdings for Consonance Capital Management

Consonance Capital Management holds 35 positions in its portfolio as reported in the March 2021 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
United Therapeutics Corporation (UTHR) 10.0 $93M 558k 167.27
Springworks Therapeutics (SWTX) 9.4 $88M 1.2M 73.57
Macrogenics (MGNX) 8.4 $79M 2.5M 31.85
Protagonist Therapeutics (PTGX) 7.5 $70M 2.7M 25.90
Keros Therapeutics (KROS) 5.8 $55M 890k 61.55
Affimed Therapeutics B V 5.1 $48M 6.0M 7.91
Deciphera Pharmaceuticals (DCPH) 4.8 $45M 994k 44.84
Mirati Therapeutics 4.7 $44M 255k 171.30
Turning Point Therapeutics I 4.5 $43M 450k 94.59
Globus Med Cl A (GMED) 3.8 $36M 578k 61.67
Arvinas Ord (ARVN) 3.2 $30M 460k 66.10
Verastem 2.9 $28M 11M 2.47
Gamida Cell SHS (GMDA) 2.9 $27M 3.3M 8.09
Legend Biotech Corp Sponsored Ads (LEGN) 2.8 $26M 897k 29.02
Casi Pharmaceuticalsinc Com Stk 2.7 $25M 11M 2.40
Iovance Biotherapeutics (IOVA) 2.7 $25M 790k 31.66
Atara Biotherapeutics (ATRA) 2.6 $24M 1.7M 14.36
Stereotaxis Com New (STXS) 2.5 $24M 3.5M 6.72
Infinity Pharmaceuticals (INFIQ) 2.3 $21M 6.6M 3.23
Nkarta (NKTX) 2.0 $19M 570k 32.90
Adicet Bio (ACET) 1.7 $16M 1.2M 13.08
Conformis 1.4 $13M 13M 0.99
Consonance Hfw Acquisition C Unit 99/99/9999 1.0 $9.8M 1.0M 9.76
Sio Gene Therapies Common 0.9 $8.3M 3.2M 2.61
Cti Biopharma 0.8 $7.3M 2.5M 2.91
Cellectar Biosciences Com Par 0.7 $6.6M 4.1M 1.61
ImmunoGen 0.6 $5.7M 704k 8.10
Silence Therapeutics Ads (SLN) 0.5 $5.1M 222k 23.00
Research Alliance Corp Ii Com Cl A 0.3 $3.1M 300k 10.25
Deerfield Healthcare Tech Ac Unit 07/16/2025 0.3 $3.0M 230k 13.10
Medicus Sciences Acquisition Unit 99/99/9999 0.3 $3.0M 300k 9.85
Jiya Acquisition Corp Com Cl A 0.3 $3.0M 300k 9.84
Arya Sciences Acqu Corp Iv Cl A (ARYD) 0.3 $2.6M 250k 10.47
Bctg Acquisition Corp 0.2 $2.0M 180k 11.12
Helix Acquisition Corp Com Cl A 0.2 $1.5M 150k 10.20